Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Marketing Agreement for Prion Filter

By Labmedica staff writers
Posted on 25 Aug 2004
A strategic alliance has been announced that will focus on the marketing and further development of products for the selective adsorption of prions and viruses from blood and blood-derived products.

Pathogen Removal and Diagnostic Technologies, Inc. More...
(PRDT), a joint venture of ProMetic Life Sciences (Cambridge, UK) and the American Red Cross (Washington, DC, USA) have formed an alliance with MacoPharma (Lille, France), a large distributor of blood collection bag sets, to market the first commercially available prion filter for red blood cells.

PRDT scientists have identified lead ligands capable of specifically targeting certain types of viruses that remain a challenge to the blood industry. The company's prion-removal ligands are the only products that address the selective adsorption of infectious prion proteins, states ProMetic. The ligands were shown to be successful in preliminary studies. The product line may ultimately target a number of viruses by the onsite filtration of donor blood supplies in blood transfusion centers, in order to reduce the risk of transmission of viruses such as West Nile virus and hepatitis C.

"PRDT's technology is an innovative breakthrough for the blood industry, and our market position in Europe will be consolidated,” said Herve Dubly, president of MacoPharma.





Related Links:
Prometic
MacoPharma

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.